Concepedia

Nikita Arya

NA

7

Publications

463

Citations

7

H-Index

2007

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Sarah Cannon

Research Triangle Park Foundation

Nikita Arya is an author at GlaxoSmithKline (United States) specializing in cancer research, oncology, and cancer therapeutics.

Top concepts

Publications per year

2007–2018

7

Publications

7

Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer

Anna Maria Storniolo, Mark D. Pegram, Beth Overmoyer et al. · Journal of Clinical Oncology · 2008 · 119 citations · Full text

A Phase I and Pharmacokinetic Study of Lapatinib in Combination with Letrozole in Patients with Advanced Cancer

Quincy S. Chu, Mary Cianfrocca, Lori J. Goldstein et al. · Clinical Cancer Research · 2008 · 71 citations

Phase I and Pharmacokinetic Study of Lapatinib and Docetaxel in Patients With Advanced Cancer

Patricia LoRusso, Suzanne F. Jones, Kevin M. Koch et al. · Journal of Clinical Oncology · 2008 · 69 citations · Full text

Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Quincy S. Chu, Garry Schwartz, Johann S. de Bono et al. · Journal of Clinical Oncology · 2007 · 62 citations · Full text

Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects

Deborah A. Smith, Kevin M. Koch, Nikita Arya et al. · British Journal of Clinical Pharmacology · 2009 · 60 citations · Full text

Rows per page

1–5 of 7